Gallagher Duncan 4
4 · Health Catalyst, Inc. · Filed Jan 2, 2025
Insider Transaction Report
Form 4
Gallagher Duncan
Director
Transactions
- Sale
Common Stock
2024-12-30$6.93/sh−4,500$31,184→ 69,938 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on May 26, 2024 in accordance with Rule 10b5-1.